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Summary
Background Climate change threatens to undermine the past 50 years of gains in public health. In response, the 
National Health Service (NHS) in England has been working since 2008 to quantify and reduce its carbon footprint. 
This Article presents the latest update to its greenhouse gas accounting, identifying interventions for mitigation 
efforts and describing an approach applicable to other health systems across the world.
Methods A hybrid model was used to quantify emissions within Scopes 1, 2, and 3 of the Greenhouse Gas Protocol, 
as well as patient and visitor travel emissions, from 1990 to 2019. This approach complements the broad coverage of 
top-down economic modelling with the high accuracy of bottom-up data wherever available. Available data were 
backcasted or forecasted to cover all years. To enable the identification of measures to reduce carbon emissions, 
results were disaggregated by organisation type.
Findings In 2019, the health service’s emissions totalled 25 megatonnes of carbon dioxide equivalent, a reduction 
of 26% since 1990, and a decrease of 64% in the emissions per inpatient finished admission episode. Of the 2019 
footprint, 62% came from the supply chain, 24% from the direct delivery of care, 10% from staff commute and patient 
and visitor travel, and 4% from private health and care services commissioned by the NHS.
Interpretation This work represents the longest and most comprehensive accounting of national health-care emissions 
globally, and underscores the importance of incorporating bottom-up data to improve the accuracy of top-down 
modelling and enabling detailed monitoring of progress as health systems act to reduce emissions.
Funding Wellcome Trust.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Climate change threatens to disrupt health systems’ 
ability to deliver high-quality care and undermine the 
past 50 years of gains in public health, with more intense 
heatwaves, higher risks of flooding and damaging 
storms, and a changing pattern of emerging infectious 
diseases.1 Responsible for some 4–5% of global green-
house gas emissions, the health-care sector has a vital 
role to play in climate change mitigation efforts, which 
will not only result in substantial reductions in emis-
sions, but can often lead to enhanced patient care, staff 
satisfaction, and cost savings.1,2 These benefits occur in 
part by preventing the initial health impacts of climate 
change, while also improving wellbeing through health 
co-benefits, such as cleaner air, increased physical 
activity, and more nutritious diets.3 Importantly, these 
co-benefits can help to offset part of the costs of 
mitigation interventions.3,4
Numerous laudable examples of mitigation in the 
health-care sector exist around the world, with interven-
tions ranging from on-site renewable energy projects or 
low-carbon procurement strategies through to digital 
redesign and changes in clinical practice. WHO and 
several non-governmental organisations have worked to 
elevate these efforts, looking to spread best practices 
and engage stakeholder groups. At a national level, 
successful mitigation strategies require national-level 
data on emissions status and trends. To this end, carbon 
footprints have been published for health-care systems in 
Australia, Austria, Canada, China, Japan, and the USA, 
alongside international estimates.1,2,5–12 These studies 
have identified general patterns of contributions among 
health-care activities in each country, which can form a 
baseline for long-term mitigation planning.
The UK’s National Health Service (NHS) is the largest 
publicly funded health system in the world. Every year, the 
NHS delivers 17 million inpatient admissions from more 
than 200 hospital trusts, more than 270 million primary 
care appointments from nearly 7000 general practices, 
and prescribes more than 1·1 billion items every year. As 
the largest single-payer health-care system in the world 
and the biggest employer in Europe, England’s NHS has 
the opportunity to leverage its size and influence to drive 
its own emissions reductions and serve as a model for 
others.13–15 The Sustainable Development Unit was created 
by the NHS in 2008 to meet the government’s commit-
ments under the UK Climate Change Act, conducting its 
first assessment of the NHS’s carbon footprint that year. 
Regularly updated and improved upon, these assessments 
now constitute the longest-running effort to quantify 
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health-care-related greenhouse gas emissions in the 
world, and are notably the only national-level analyses 
carried out by a public agency with institu tional support, 
rather than by independent researchers.
This Article represents a collaboration between the 
NHS and the Lancet Countdown and presents results 
for the most recent carbon footprint estimates for the 
NHS, covering emissions from 1990 to 2019, alongside a 




NHS England’s emissions were calculated using a hybrid 
accounting method that combines two approaches: 
(1) location-generic (top-down) results for categories that 
can only be measured in economic terms or that are too 
complex to model physically, and (2) product-specific 
and location-specific (bottom-up) results for emissions 
categories that can be measured and described physically 
(appendix 1 pp 2–3). Hybrid modelling is commonly 
used in life-cycle assessment and resource footprinting, 
representing a compromise that takes maximum 
advantage of the accuracy associated with bottom-up 
physical modelling and of the broad coverage of a system-
wide supply-chain top-down modelling.16 The analysis 
covers the period 1990–2019, allowing for benchmarking 
with the Climate Change Act. Emissions estimates for 
specific years, depending on the emissions category and 
data source, were backcasted (ie, modelled for previous 
years) or forecasted to the remaining years as noted 
(appendix 1 pp 2–3, 43–45).
The footprint analysis covers greenhouse gas emissions 
(carbon dioxide [CO2], methane [CH4], nitrous oxide 
[N2O], and some categories of fluorinated gases) under 
Scopes 1, 2, and 3 of the Greenhouse Gas Protocol, as 
well as personal travel emissions, which are not normally 
considered within the Greenhouse Gas Protocol but over 
which the NHS has considerable influence (figure 1).17 
Scope 1 covers direct emissions from health-care 
facilities, Scope 2 covers emissions from purchased 
energy such as electricity and steam, and Scope 3 covers 
all other emissions. Emissions were further organised 
into four categories: delivery of care, personal travel, 
supply chain, and commissioned services—ie, clinical 
services procured from private health-care pro viders 
Research in context
Evidence before this study
While the world responds to the COVID-19 public health 
emergency, climate change, driven by anthropogenic 
greenhouse gas emissions, remains a long-term threat to the 
health and wellbeing of world populations, and the increasing 
pressure it poses on health-care systems threatens to 
undermine the past 50 years of gains in public health.
The health sector has been shown to contribute to 4–5% of 
global greenhouse gas emissions, and its response is key not 
only to mitigate climate change, but especially to ensure that 
the health benefits of this transition are maximised. In line with 
this goal, researchers in Australia, Austria, Canada, China, Japan, 
and the USA have estimated the emissions profile of national 
health systems, and multicountry studies have been done by 
research institutions and non-governmental organisations. 
In England, the Sustainable Development Unit has published 
regular updates of the National Health System (NHS)’s carbon 
footprint since 2008, making it the longest-running and only 
such effort carried out by a governmental body rather than 
independent researchers, for what is the largest publicly funded 
health system in the world.
Added value of this study
The NHS carbon footprint presented here is aligned with the 
Greenhouse Gas Protocol, covering Scopes 1, 2, and 3 as well as 
other personal travel (patient and visitor travel) that would not 
normally be included in an organisation’s footprint. It uses a 
hybrid modelling approach that takes advantage of the 
accuracy associated with bottom-up data and the broad 
coverage of top-down economic input–output modelling. 
The disaggregation of greenhouse gas emissions by type of 
clinical activity, as well as per unit of health-care provision, 
further enables the identification of long-term mitigation 
interventions. This work therefore represents the most 
comprehensive and sophisticated health-care footprinting 
effort to date.
In 2019, the carbon footprint of the NHS in England totalled 
25·0 megatonnes of carbon dioxide equivalent, of which 
62% came from its supply chain (including emissions imported 
in foreign goods and services) and only 24% from the delivery 
of care scope, stressing the importance of a coordinated 
international effort to achieve a robust decarbonisation of 
health care. Importantly, 10% of emissions came from travel to 
and from NHS sites by patients, visitors, and staff commute, 
over which the health systems can have a considerable degree 
of influence through innovations in models of care.
Implications of all the available evidence
Due to its sizeable contribution to global greenhouse gas 
emissions and the health benefits of transitioning towards a 
low-carbon economy, health systems have a central role to play 
in climate change mitigation efforts. This work lays out a robust 
methodology for health-care system footprinting that can help 
to guide efforts in other countries as they monitor their own 
health-care emissions. It also underscores the importance of a 
comprehensive and broad scope approach for tracking the full 
impact of health-care provision and the need for investing in 
bottom-up data collection through robust and validated 
information systems to increase the accuracy and resolution of 
emissions accounting and inform focused interventions.
See Online for appendix 1
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(figure 1). Delivery of care Scope 3 encompasses 
emissions that occur during use and therefore can be 
strongly influenced by how care is provided. For each 
category, emissions were calculated by multiplying 
the quantity of consumption (eg, electricity use) by the 
corresponding emissions factor (CO2 equivalent [CO2e] 
mass of emissions per consumption unit). Results are 
presented for the NHS in England as a whole and 
disaggregated by organisation. To account for changes in 
the volume of health-care provision, results were also 
normalised against the number of inpatient finished 
admission episodes (FAEs; defined as a single inpatient 
admission in the year), health-care expenditure, and 
total population. Additional methodological details are 
provided in appendix 1 (p 42).
Building emissions
Building emissions include Scope 1 fuel use, Scope 2 
electricity use, and Scope 3 upstream energy emissions 
(eg, from emissions from oil and gas extraction, and 
distribution losses). Data from the Estates Return 
Information Collection (ERIC) system—a compre-
hensive national-level database—were used to estimate 
emissions from NHS buildings. ERIC collates data from 
NHS trusts and ambulance trusts within England, 
including the consumption of energy, water, and limited 
other goods for all buildings and NHS-leased sites, 
covering 24 million m² of hos pitals and other clinical 
facilities across the country (appendix 1 pp 4–6), and is 
subject to robust validation.18 Importantly, it does not 
include other health-care buildings such as those for 
primary care, sites smaller than 150 m² with fewer than 
ten inpatient beds, or office buildings of non-clinical 
organisations. Energy use for these excluded building 
types was estimated for 2015 and comprised approxi-
mately 15% of total NHS energy use (appendix 1 p 7). 
ERIC reporting requirements and NHS structures have 
changed over time and an annual adjustment was 
included to account for this. Corresponding emissions 
factors for fuels and electricity were taken from the 
UK Government energy (Department for Business, 
Energy & Industrial Strategy [BEIS]) and environment 
(Department for Environment, Food & Rural Affairs) 
ministry publications for 2002–19, and from company 
reporting guidance for older calcula tions (appendix 1 
p 8).19,20 Electricity generated by on-site combined heat 
and power plants was accounted for using fossil fuel 
consumption emission factors rather than grid electricity 
factors.
Anaesthetic gases and metered dose inhalers
In addition to emissions associated with manufacturing 
(counted in the supply chain), some pharmaceuticals 
have emissions released on site (Scope 1), such as 
anaesthetic gases, inhaled medicine propellants, and 
other medical and surgical gases. Volatile anaesthetics 
(sevoflurane, isoflurane, and desflurane) and N2O are 
potent greenhouse gases that are routinely released 
unmetabolised into the atmosphere. This analysis 
used four categories of data sources to estimate these: 
supplier data from distribution or manufacturing 
companies, voluntary health-facility reporting, NHS 
pharmacy electronic data repository (volatiles only), and 
dental clinic N2O data from work commissioned by 
Public Health England.21 UK data were scaled to England 
by population, and all bottom-up data were extrapolated 
to England by occupied bed-days. In each case, Global 
Warming Potential factors for the volatiles were taken 
from Sulbaek Anderson et al22 and for N2O from the 
Intergovernmental Panel on Climate Change’s Fifth 
Assessment Report (IPCC AR5).23
Metered dose inhalers (MDIs) use chlorofluorocarbon 
or hydrofluorocarbon propellants that do not undergo 
metabolic transformation and are released unchanged 
into the atmosphere. The emissions occur wherever 
patients use them, and are treated as Scope 3. Emissions 
data based on number of prescriptions have been 
reported to the National Atmospheric Emission Inventory 
since 2006, and were backcasted to 1990 using popula-
tion data and assuming no change in inhaler use per 
capita before 2006 (appendix 1 pp 43–45).24 Corresponding 
emission factors are from the IPCC AR5.23
Supply chain emissions and commissioned health 
services
Multiregion input–output (MRIO) modelling was used to 
determine the contribution of Scope 3 supply chain 
emissions to the carbon footprint of the NHS in England. 
The methodology uses the UK MRIO model alongside 
the Public Expenditure Statistical Analysis Supply and 
Use tables from HM Treasury to derive emissions 
associated with first-tier procurement categories.25–27 In 
input–output modelling, consumption is represented by 
monetary expenditures rather than physical quantities. 
The NHS’s internal spending information does not 
capture breakdown by economic sector and so was not 
Figure 1: Sources of emissions organised by Greenhouse Gas Protocol Scopes and by NHS emissions categories
Columns represent NHS emission categories and rows the Greenhouse Gas Protocol Scopes. NHS=National Health 
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used; instead, total spending on health care tracked by 
HM Treasury was proportioned using the transaction 
matrix in the UK MRIO model. This matrix maps 
the total NHS expenditure to 106 sectors for each of 
four world regions (UK, China, EU, and Rest-of-World 
regions; appendix 1 pp 9–20). Emissions factors for each 
of the resulting 424 sectors, covering all Kyoto Protocol 
greenhouse gases including all embodied, cradle-to-gate 
emissions, were calculated from the UK MRIO satellite 
accounts (appendix 1 pp 21–31).28 Emissions were then 
calculated by multiplying sectoral expenditure data and 
the corresponding emissions factors.
The raw results were then aggregated using a concor-
dance-based approach. This process maps emissions into 
19 expenditure categories. Nine of these relate to Scope 1 
and 2 emissions and were removed as they are accounted 
for elsewhere via bottom-up calcula tions (appendix 1 
pp 32–34). Discontinuities resulting from sector reclassi-
fication or MRIO model updates were replaced with 
interpolated values to conform with long-term trends. 
Beyond its supply chain, the NHS commis sions health 
and care services from other providers including private 
hospitals and third parties—eg, for community services. 
Emissions (Scope 3) asso ciated with these expenditures 
were estimated using the UK MRIO model, matched to 
the economic sector UK Human Health Activities.
Travel emissions
Travel emissions include fleet travel (Scope 1), business 
travel and staff commuting (Scope 3), and personal 
patient and visitor travel (additional induced emissions 
not covered by the Greenhouse Gas Protocol). Emissions 
from fleet travel using vehicles owned or leased by the 
NHS or business travel otherwise funded by the health 
services were accounted for using the top-down 
UK MRIO model based on expenditures on travel (see 
section on supply chain emissions), while emissions 
from personal travel by staff (commuting), as well as 
patients and visitors to and from NHS sites were 
accounted using bottom-up data (appendix 1 p 35). For 
staff, bottom-up data were gathered from the Department 
for Transport in 2015 and 2019 for average distance 
travelled per trip (appendix 1 p 36). Patient and visitor 
travel data were recorded in the UK National Travel 
Survey (appendix 1 p 37). Emissions factors from BEIS 
were mapped to each mode of travel, including both 
Scope 1 (direct emissions) and Scope 3 (well-to-tank 
emissions; appendix 1 p 38).19
Allocation to organisations
Carbon emissions for each NHS emissions category 
were further disaggregated to six organisation types—
ambulance, community, mental health, acute, primary 
care, and non-clinical support activities—using a 
combination of top-down and bottom-up data as 
appropriate to the emissions category. For bottom-up 
estimates, energy use, travel estimates based on activity 
and numbers of journeys, anaesthetic gas use, and MDI 
numbers were allocated on the basis of internal data; 
for top-down estimates, the share of expenditures were 
used.29 All data used for allocating emissions were 
specific to 2018–19 operations and scaled to 2019.
Uncertainty
Due to the hybrid approach combining multiple bottom-
up datasets with top-down MRIO-based results, it was 
not feasible to conduct a comprehensive uncertainty 
analysis, such as the Monte Carlo simulation-based 
analyses done for MRIO-only studies of health-care 
emissions.5,6 Bottom-up datasets used for this analysis, 
including building energy use and anaesthetic gas and 
MDI use, did not have reported error values. For the 
MRIO-based results, previous work can provide context: 
an uncertainty analysis done for an earlier version of 
the UK MRIO model found that total UK consumer 
greenhouse gas emissions carried a relative SE of 
approximately 4–6%; previous health-care footprinting 
analyses found an SD of less than 5% globally and 
relative SEs of approximately 15% for China and 28% for 
Australia.5,6,30 Qualitative sources of uncertainty are 
elaborated on in the Discussion.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, writing of 
the report, or the decision to submit the paper for 
publication. All authors had full access to all the data in 
the study and had final responsibility for the decision to 
submit for publication.
Results
For 2019, the most recent year of our analysis, the carbon 
footprint for the NHS in England was estimated at 
25 megatonnes (Mt) of CO2e, representing a decrease of 
approximately 26% from 1990 (figure 2; appendix 1 p 39). 
A substantial contributor to this reduction has been 
the decarbonisation of the energy system, which has 
contributed to the 64% reduction in building energy 
from 1990 to 2019 observed in figure 2 and was the main 
driver of a 43–45% decrease in total national greenhouse 
gas emissions over the same time period.31,32 At the same 
time, the population of England increased by 17%; the 
pro vision of care doubled, measured as the number of 
inpatient FAEs; and health spending more than tripled 
in real terms. This translated to a reduction in the carbon 
intensity of the NHS of 37% for CO2e per capita and 
64% per inpatient FAE between 1990 and 2019 (figure 3; 
appendix 1 pp 40–41).
In 2019, the largest share of emissions by far were 
from the supply chain (62% [15·6 Mt CO2e]), followed 
by delivery of care (24% [6·1 Mt CO2e]), and travel to 
and from NHS sites by patients and visitors and staff 
commuting (10% [2·4 Mt CO2e]; figure 4; appendix 1 
p 39). Private health and care services commissioned 
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by the NHS contributed the final 4% (1·0 Mt CO2e). 
Supply chain emissions were dominated by the 
manufacturing of goods such as pharmaceuticals and 
chemicals (32% [5·1 Mt CO2e]), and medical equipment 
(19% [3·0 Mt CO2e]); however, emissions associated with 
the provision of business services (17% [2·7 Mt CO2e]) 
such as indemnity insurance also comprised an 
important component (figure 4; appendix 1 p 39). The 
construction of health-care facilities and freight transport 
of goods, activities often high lighted in sustainability 
efforts, contributed to only 5% (0·8 Mt CO2e) and 
6% (1·0 Mt CO2e) of supply chain emissions, respectively.
Figure 2: Time series results for the greenhouse gas emissions of the NHS in England, broken down by source of emission, 1990–2019
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Figure 3: Greenhouse gas emissions for the NHS in England, presented as total emissions (A), emissions per inhabitant (B), emissions per real unit of spending (C), 
and emissions per inpatient FAE (D)
Data available in appendix 1 (pp 40–41). Real spending is calculated in terms of GBP for the 2018–19 financial year. FAE=finished admission episode. GBP=British 
pound. Mt CO2e=megatonnes of carbon dioxide equivalent. NHS=National Health Service.
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Overall, NHS England’s greenhouse gas emissions 
have gone through three distinct phases since 1990 
(figure 2; appendix 1 p 39). In the first phase, from 1990 
to 2000, emissions fell steeply from 33·8 Mt CO2e to 
27·5 Mt CO2e, driven largely by the phase-out of 
chlorofluorocarbon propellants in inhalers in compliance 
with the Montreal Protocol,33 reduced reliance on coal 
and oil for onsite heating, and by reductions in supply 
chain emissions from pharmaceuticals, chemicals, and 
gases as technologies improved. In the second phase, 
from 2001 to 2012, overall emissions grew again, 
reaching 27·8 Mt CO2e, driven by investment in health 
care from 4·7% to 7·6% of gross domestic product 
in 2009, and subsequent increased supply chain 
emissions, from 13·3 Mt CO2e in 2001 to 15·7 Mt CO2e 
in 2012. Emissions from commissioned health-care 
activities approximately tripled also over this period, 
from 0·3 Mt CO2e to 1·1 Mt CO2e. In the third phase, 
from 2013 to 2019, overall emissions fell again, led by 
reductions in emissions from electricity generation as 
the UK grid has rapidly decarbonised.
When considering emissions based on clinical activity 
for 2019, it is clear that, unsurprisingly, health care 
pro vided by acute services takes place in the most 
resource-intensive clinical settings and is the largest 
contributor overall, comprising more than half (56%) of 
total emissions (table). Primary care contributions derive 
primarily from the supply chain and prescriptions of 
MDIs. When considered by unit of activity, this results 
in an estimated carbon footprint of 125 kg CO2e per 
bed-day and 76 kg CO2e per outpatient appointment for 
acute care, 66 kg CO2e per general practice visit, and 
75 kg CO2e per ambulance emergency response, among 
others.29
Discussion
Carbon footprint results for the NHS in England reveal 
the most influential sources of emissions throughout the 
health-care system, and how each has changed over the 
past three decades, allowing the foundation of strategic 
planning going forwards. Enhanced efforts for national 
Figure 4: Contribution of different sectors to the greenhouse gas emissions of the NHS England, 2019































































Building energy 21 150 164 1900 250 31 2520
Anaesthetic gases and metered 
dose inhalers
84 0 0 435 767 0 1290
Water and waste 16 85 95 883 137 88 1300
Business travel and fleet 200 100 120 410 60 110 1000
Supply chain
Pharmaceuticals and chemicals 5 120 66 2095 2750 26 5060
Medical equipment 16 147 55 1930 248 128 2520
Non-medical equipment 38 156 170 1040 420 137 1960
Other procurement 100 384 465 2850 610 1620 6030
Commissioned services 3 15 26 90 0 826 960
Personal travel 27 120 350 1326 536 43 2400
Total 510 1280 1510 12 960 5770 3010 25 040
Data are kilotonnes of carbon dioxide equivalent. Totals might vary due to rounding.
Table: Clinical activity-based greenhouse gas emissions by emissions category, 2019
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and global trends will also be key to achieve emissions 
reductions goals. The NHS’s 2019 Long-Term Plan 
describes a wide variety of commitments to the digital 
redesign of health care, improvements in technology, 
and renewed climate change mitigation ambitions.34 
Although the NHS can influence all emissions sources, 
its ability to effect changes varies considerably.
The NHS has the most direct operational control over 
its delivery of care emissions (figure 1); this source 
category made up fully a quarter of overall emissions 
in 2019. Numerous interventions are already being 
implemented across NHS estates and facilities, with 
others targeted in its strategic planning. Engineering and 
sociotechnical interventions are staged first and include 
widespread insulation and upgrading of building 
envelopes, efficient appliances, and more sophisticated 
control systems, which could reduce energy use by an 
estimated 40%. The next step, which will need to overlap 
in time with the energy reduction interventions, 
is to convert gas boilers to electric heat pumps, thereby 
improving efficiency and switching to a lower-carbon 
energy source. Once buildings are fully electrified 
(with appropriate technology to provide backup systems), 
grid decarbonisation will deliver emissions reductions. 
The carbon intensity of UK grid electricity is projected 
to fall from current levels of 288 kg CO2e/MWh to 
27 kg CO2e/MWh in 2050, and potentially to zero 
under the UK Government’s commitment to reach 
Net Zero by 2050.35 NHS facilities could decarbonise 
more rapidly by installing on-site solar photovoltaics or 
wind generation. The earlier this occurs, the greater 
the emissions benefit will be relative to grid electricity, 
which will decline over time. Considering other sources 
within delivery of care, emissions from water, wastewater, 
and solid waste can be reduced through water efficiency 
projects and waste reduction measures, including 
reducing the use of single-use consumables.
While many of the interventions above focus on 
health-care facility operations, optimising how clinical 
care is delivered is at the heart of the NHS mission and is 
a major focus of sustainability efforts, led by clinicians 
and staff. Focusing on in-use emissions from pharma-
ceuticals, emissions of waste anaesthetic gases can be 
addressed through the reduction of fresh gas flows and 
low-carbon drug selection by clinicians; destruction 
technologies are also available for nitrous oxide, while 
the development of capture technologies for volatile 
anaesthetics shows promise for the near future. Inter-
ventions to mitigate MDI emissions include conversion 
to dry powder inhalers (with no gas propellant) when 
feasible, expanding patient education efforts to maximise 
correct usage, and incentivising pharmacy take-back 
programmes to safely dispose of partially spent MDIs.36 
Although only a small component of health-care activity, 
emissions from anaesthetic gases and MDIs can make 
up a substantial proportion of health-care emissions and 
should be considered with a dedicated stream of analysis.
Importantly, health promotion and disease prevention 
programmes such as public health campaigns and social 
prescribing can reduce the overall demand for health care, 
while the selection of a less carbon-intensive and resource-
intensive care practices where clinically appropriate can 
reduce both emissions and costs. The activity-based 
emissions results could be used to set priorities in disease 
prevention, as well as development and adoption of lower 
carbon best practices.
Supply chain emissions are the largest source category 
but are the most difficult to influence directly. Two impor-
tant general strategies are reducing the overall demand for 
goods and services (eg, through reducing drug wastage or 
refurbishing and reusing devices) and shifting to low-
carbon goods and services (eg, through specifying so-called 
green concrete, low-carbon data services, or plant-based 
diets). The NHS has produced several tools to guide green 
procurement, including footprinting guidance and reports 
identifying the most carbon-intensive purchased items 
and pharmaceuticals.37 The last option is to reduce the 
overall emissions intensity of manufactured goods and 
services, which will include emissions taking place in the 
UK and foreign countries. In many countries, reductions 
are already occurring by virtue of energy system decar-
bonisation and the upgrading of industrial equipment. 
The NHS can incentivise further and faster progress 
through partnerships with tier 1 suppliers that pledge 
aggressive emissions reduction targets.
Finally, for transport, the most impactful interventions 
will be to promote active travel and public transit to and 
from NHS sites, as well as the phasing in of electric 
ambulances and other NHS vehicles. These interventions 
will also benefit health through reduced local air 
pollution, reducing vehicular accidents, and increasing 
physical activity.38,39 Shifting modes of care can also avoid 
travel for in-person visits, including telehealth moni-
toring of long-term conditions, remote diagnostics, and 
virtual appointments, with particular health benefits to 
those with reduced mobility, and reducing exposure of 
patients to hospital environments and possible health-
care-acquired infections.
Per-capita results for the NHS in England (plus social 
care and public health) of 540 kg CO2e per capita 
compared with similar national studies of health-
care sectors place it in proximity to results for Japan 
(566 kg CO2e per capita in 2015) but less than those for 
Austria (799 kg CO2 per capita in 2014, CO2 only), Canada 
(899 kg CO2e per capita in 2015), Australia (1,495 kg CO2e 
per capita in 2015), and the USA (1889 kg CO2e per capita 
in 2013).5,7,9,10,12 Among previous national studies, only 
Nansai and colleagues7 for Japan have provided results 
by activity (and also by disease type and age cohort), 
and only Weisz and colleagues9 for Austria have made 
use of bottom-up data. Other international studies have 
evaluated the UK health-care carbon footprint; these use 
aggregated health expenditure data and environmentally 
extended MRIO models without bottom-up data and are 
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not directly comparable to the results presented here. 
On a per-capita basis, Pichler and colleagues11 estimated 
640 kg CO2 per capita (CO2 only) in 2014. International 
input–output-based estimates can differ in magnitude 
from bottom-up estimates because they more completely 
capture upstream emissions.
Our analysis represents the most detailed national 
health-care carbon footprinting effort to date, enabled by a 
wealth of bottom-up data and the use of the sophisticated 
UK MRIO model, which combines the high sectoral 
resolution of UK input–output tables with the comprehen-
sive representation of international economic structures 
and emission intensities of an MRIO model. Moving 
forwards, as the NHS continues to track its progress, 
further data improvements will become essential to 
reflect progress on emissions reductions. For this, the 
vintage of individual datasets and models is an important 
consideration. For example, input–output tables for the UK 
are published with a 4-year lag (current latest information 
is for 2016) and so carbon intensities and expenditure 
apportionments must be carefully projected to reflect 
current conditions. For some emissions categories, data 
are only available for a subset of years and are currently 
extrapolated (appendix 1 pp 2–3, 43–45). These projections 
contribute to the uncertainty of the results, as do other 
factors including the blending of bottom-up and top-down 
analyses in a hybrid model, the matching of supply chain 
sectors to categories in the MRIO concordance, and the 
estimation of missing bottom-up data where completeness 
of the MRIO model cannot be used. Improved data 
monitoring and collection will provide more robust and 
high-resolution results that can be used at the individual 
facility level—eg, using financial and vehicle audit data to 
create bottom-up business transport datasets rather than 
using top-down modelling. Finally, including emissions 
of hydrofluorocarbons used as refrigerants as well as of 
sulphur hexafluoride used in some eye surgeries will 
ensure that the complete set of Scope 1 greenhouse gases 
is being included.
In conclusion, as health systems respond to the 
increasing health impacts of climate change on global 
populations, they both contribute to the problem, 
generating 4–5% of global greenhouse gas emissions, 
and have a central role to play in the solution.1 
Acknowledging this, the NHS has put more than a 
decade’s worth of work in measuring and monitoring its 
greenhouse gas emissions, with the results recorded 
in this Article. This represents the first and imperative 
step to enable the identification and subsequent mitiga-
tion of greenhouse gas emissions, with sustained 
investment required for the analysis to be useful for 
long-term planning and strategic decision making. In 
assessing the applicability of these methods to health 
systems in other countries, a number of key features 
are apparent. First, adopting a hybrid model provides 
flexibility and balances the need for a comprehensive 
assessment with the availability of bottom-up data. 
Countries have varying levels of coverage and quality in 
bottom-up data, which should be used and improved 
where possible, as these can be used to monitor and 
support local actions. Second, any bottom-up data 
should be regularly updated and validated to ensure that 
results are timely and reflect changes in health-care 
investments, demographics, and emissions intensities. 
Finally, it is important that any mitigation efforts actively 
seek to generate health co-benefits, reduce environmental 
impacts, and maintain or improve quality of care. Only 
then will health systems comply with their duty to first, 
do no harm.
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